Evaluation of the 7th ESC Congress "Changing attitudes to Contraception and Reproductive Health" in Genova, Italy, April 10 - 13, 2002 given by participants of the congress.

Introduction  Evaluation of the congress speakers

Introduction  

Evaluation of contributions to congresses and seminars is seen by the ESC as a tool of quality control. Evaluation can also contribute to the continuation of high standards of congresses and seminars and where possible make improvements for the future. Therefore the ESC asked participants of the 7th Congress of the European Society for contraception, "Changing attitudes to Contraception and Reproductive Health", which was held in Genova, 10-13th of April 2002, to fill in an evaluation form and score the sessions attended. A total of 40 contributions were evaluated, 241 forms were fit for evaluation. The number of hits per contribution varied from 42 to 198. This means that relative to the total number of participants the number of evaluation forms is rather low. On the other hand the participants in general were very satisfied with the quality of the contributions. In a scale from 1 ‘poor’ to 5 ‘excellent’ the average score was 4,2! The single contribution which scored highest, was the closing session ‘Future contraception form research to practice’ which scored an excellent 4,5. Other topics, which scored very high, were the contributions on sexual transmitted viral infections and the meet the expert’s session on sexual dysfunction and contraception. All the main session speakers scored 4 or more, but even of the contributions, which scored a little lower, all were at least satisfactory or higher. The ESC can be very content with this evaluation. A point of improvement the next time will be to convince the participants how important it is to fill in these evaluation forms.

 

Evaluation of the congress speakers

Theme of lecture Session * **
Contraception and Society Opening Lecture 4,2 193
Steroid receptors Main Session I From Biology to Contraception 4,1 191
New progestins Main Session I From Biology to Contraception 4,1 198
Implantation Main Session I From Biology to Contraception 4,1 195
Legislation Session 1: Abortion situation in Europe 3,9 109
Statistical information Session 1: Abortion situation in Europe 3,7 109
Changing attitudes towards abortion Session 1: Abortion situation in Europe 3,9 118
Long acting methods Meet the Experts 3 80
Psychological aspects Meet the Experts 3,8 68
The role of the non medical professionals in contraception Meet the Experts 3,9 63
OC use and endometriosis Meet the Experts 3,8 42
Contraception in PCO patients Meet the Experts 4 81
Spermicides Meet the Experts 3,5 52
Breast, ovary, endometrium and cervix Session 4: Cancer and contraception 3,5 168
IUD Workshops 4 69
Adolescent forum Workshops 4 90
The Web as a teacher in the contraceptive field Workshops 3,3 48
Continuation and compliance of contraceptive use Session 6: What do women want? 3,8 113
Counselling in contraception Session 6: What do women want? 4,1 127
Anti-ovulatory effects of progestin preparations Main Session II Progestin-only contraception 4,2 181
Clinical profile of progestin contraception Main Session II Progestin-only contraception 4,1 153
Mode of delivery systems (impact on acceptability) Main Session II Progestin-only contraception 4 130
Male contraception with androgen plus progestin Session 2: Male contraception 4,1 126
Other possibilities Session 2: Male contraception 4 108
Psychological aspects Session 2: Male contraception 3,8 109
Adolescent contraception Meet the Experts 4,2 69
Non-bleeding OC regimens Meet the Experts 4,2 49
Early medical abortions Meet the Experts 3,9 46
Non-viral STD Meet the Experts 3,9 45
Fertility regulation in the perimenopause Meet the Experts 4,2 53
Sexual dysfunction and contraception Meet the Experts 4,3 54
Clinical aspects Session 5: Emergency contraception 4,2 87
Over the counter Session 5: Emergency contraception 4,1 67
Evidence based contraceptive practice Workshops 4 59
Hepatitis Main Session III Sexual transmitted viral infections 4,1 72
HIV Main Session III Sexual transmitted viral infections 4,3 78
HPV Main Session III Sexual transmitted viral infections 4,3 80
Biologic effects Session 3: Oral contraception and CVD 4,1 75
Epidemiologic effects Session 3: Oral contraception and CVD 4 72
Future contraception, from research to practice Main Session IV 4,5 47
LEGEND:
* score on 5 scale: 5 = excellent, 4 = good, 3 = average, 2 = below average, 1 = poor
** number of hits = number of persons who evaluated this speaker (total of participating persons to evaluation: 241)

(back to news) (back to ESC congress)

home